Published in Proc Natl Acad Sci U S A on March 16, 1999
Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A (2002) 2.62
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am J Pathol (2002) 1.06
Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br J Ophthalmol (2005) 1.04
Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. Biochemistry (2007) 0.98
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ. J Neurochem (2011) 0.95
Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope. Biochemistry (2007) 0.91
Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol (2013) 0.84
An antibody raised against a pathogenic serpin variant induces mutant-like behaviour in the wild-type protein. Biochem J (2015) 0.81
Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component. PLoS One (2013) 0.81
Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD. J Cell Mol Med (2013) 0.79
Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations. Protein Sci (2010) 0.79
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin. Amyloid (2016) 0.76
Novel Antibody for the Treatment of Transthyretin Amyloidosis. J Biol Chem (2016) 0.75
Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions. PLoS One (2017) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol (1978) 4.47
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett (1992) 4.29
Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure (1996) 3.58
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry (1996) 3.42
Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry (1992) 3.19
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun (1988) 2.13
Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. J Mol Biol (1998) 1.88
Cross- protein structures. I. Insulin fibrils. Biochemistry (1972) 1.72
Transthyretin mutations in health and disease. Hum Mutat (1995) 1.58
The crystal structure of amyloidogenic Leu55 --> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem (1998) 1.22
Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP). Biochemistry (1991) 1.21
Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes. EMBO J (1987) 1.18
Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J (1993) 1.12
Thyroxine-binding prealbumin. Conformation in aqueous solutions. J Biol Chem (1971) 0.94
Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. Amyloid (1998) 0.93
Characterization of two highly amyloidogenic mutants of transthyretin. Biochemistry (1997) 0.90
Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J (1993) 0.86
Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochim Biophys Acta (1992) 0.84
Advances in amyloidosis. Curr Opin Rheumatol (1993) 0.81
Modulating conformational factors in transthyretin amyloid. Ciba Found Symp (1996) 0.80
Genetic mapping of quantitative trait loci for growth and fatness in pigs. Science (1994) 5.37
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63
Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron (1993) 3.44
Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study. Br J Cancer (1981) 3.34
Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia. EMBO J (1983) 3.27
Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science (1984) 3.24
Multiple marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs. Genetics (1998) 2.80
A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J (1991) 2.73
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell (1990) 2.46
Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest (1984) 2.41
Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1977) 2.26
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron (1990) 2.22
Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res (1982) 2.19
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med (1995) 2.08
Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell (1985) 2.06
Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect Immun (1995) 2.02
Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron (1991) 2.02
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci U S A (1978) 1.94
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat Genet (1999) 1.91
Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol (2001) 1.91
High-energy surface X-ray diffraction for fast surface structure determination. Science (2014) 1.84
Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 1.84
Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol (1980) 1.82
Myelinated nerve fibres in the CNS. Prog Neurobiol (1993) 1.79
Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol (1993) 1.78
Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron (1991) 1.74
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia (2007) 1.73
Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol (1999) 1.72
A cohort study on trichloroethylene exposure and cancer mortality. J Occup Med (1978) 1.72
A study of 136 cases of adder bite treated in Swedish hospitals during one year. Acta Med Scand (1981) 1.71
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science (1995) 1.70
Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem (2001) 1.70
Viral DNA sequences and gene products in hamster cells transformed by adenovirus type 2. J Virol (1978) 1.69
Smoking and inflammatory bowel disease. A case control study. Gut (1988) 1.69
Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products. Mol Cell Biol (1981) 1.68
Visualization of the formation and transport of a specific hnRNP particle. Cell (1983) 1.68
Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients. Eur J Cancer Care (Engl) (2006) 1.66
Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence. Proc Natl Acad Sci U S A (1980) 1.66
Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell (1992) 1.62
An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature (1982) 1.60
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J Mol Biol (1995) 1.56
Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J Med Chem (2000) 1.55
Surface properties of lactobacilli isolated from the small intestine of pigs. J Appl Bacteriol (1987) 1.52
Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience (1992) 1.52
Bio-Beads: an efficient strategy for two-dimensional crystallization of membrane proteins. J Struct Biol (1997) 1.52
Left hemisphere dominance for processing vocalizations in adult, but not infant, rhesus monkeys: field experiments. Proc Natl Acad Sci U S A (1994) 1.51
Fraud, misconduct or normal science in medical research--an empirical study of demarcation. J Med Ethics (1999) 1.49
Gene and mRNA for precursor polypeptide VI from adenovirus type 2. J Virol (1981) 1.49
The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem (1999) 1.46
A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med (1992) 1.45
Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization. Hum Hered (1973) 1.45
Pharmacological properties of 1-(3'5'-diisobutyryloxy-phenyl)-2-(t-butylamino)-ethanolhydrochloride (KWD 2058), a new sympathomimetic bronchodilator. Acta Pharmacol Toxicol (Copenh) (1974) 1.42
The Prospective Population Study of Women in Gothenburg, Sweden, 1968-69 to 1992-93. A 24-year follow-up study with special reference to participation, representativeness, and mortality. Scand J Prim Health Care (1997) 1.40
Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene (1992) 1.40
Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells. J Virol (1979) 1.39
Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J Biol Chem (1994) 1.39
[There are rules on drug prescription]. Lakartidningen (1998) 1.38
Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol (1990) 1.37
Cancer mortality of cadmium workers. Br J Ind Med (1985) 1.37
2 new groups of selective stimulants of adrenergic beta-receptors. Experientia (1969) 1.36
Expression of the beta-nerve growth factor gene in hippocampal neurons. Science (1988) 1.35
MRI acoustic noise: sound pressure and frequency analysis. J Magn Reson Imaging (1997) 1.35
Purification of a native membrane-associated adenovirus tumor antigen. J Virol (1982) 1.35
Three-dimensional structure of a specific pre-messenger RNP particle established by electron microscope tomography. Nature (1986) 1.34
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol (2000) 1.34
Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells. Mol Cell Biol (1985) 1.34
Citalopram toxicity. Lancet (1997) 1.32
Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res (1996) 1.32
YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb Pathog (1999) 1.30
Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci U S A (1992) 1.29
First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect (2000) 1.28
p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron (1994) 1.28
Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron (1989) 1.28
Rapid reformation of the thick chromosome fiber upon completion of RNA synthesis at the Balbiani ring genes in Chironomus tentans. Chromosoma (1982) 1.28
Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis. Endocrine (1997) 1.27
Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res (1988) 1.27
Improvement of semen and pregnancy rate after ligation and division of the internal spermatic vein: fact or fiction? Br J Urol (1979) 1.27
Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J Occup Med (1994) 1.26
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail (2004) 1.26
Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett (1992) 1.25
An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO J (1993) 1.25
Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev Biol (1984) 1.24
Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians (1983) 1.24
Ethylene glycol poisoning: experiences from an epidemic in Sweden. J Toxicol Clin Toxicol (1992) 1.23
Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci U S A (1993) 1.23
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
The crystal structure of amyloidogenic Leu55 --> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem (1998) 1.22
Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP). Biochemistry (1991) 1.21
Developmental and regional expression of beta-nerve growth factor receptor mRNA in the chick and rat. Neuron (1988) 1.20
Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res (1993) 1.20
Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci (2001) 1.20
Shear-dependent inhibition of granulocyte adhesion to cultured endothelium by dextran sulfate. Blood (1989) 1.20